The Pacific Meso Center (PMC) at The Pacific Heart, Lung, & Blood Institute is pleased to announce that it has agreed to help sponsor a UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, an asbestos-related cancer involving the lining of the chest (pleura). This will be the first scientific seminar of its kind featuring cancer treatments that preserve the victims' lungs. This unique one-day seminar will take place on Saturday, May 21st at the Sheraton Delfina in Santa Monica, from 8:00 a.m. to 5:00 p.m.
The course will be led by Dr. Robert B. Cameron, Director of the Mesothelioma Research Program at the David Geffen School of Medicine at UCLA, Chief of Thoracic Surgery at the West Los Angeles Veterans' Administration Medical Center, and a long-time advocate for lung-sparing surgery.
The seminar's distinguished international faculty includes both Mr. Tom Treasure, MD, and Mr. David A. Waller, MD, from England, who will discuss the recent startling results announced from the Mesothelioma and Radical Surgery (MARS) Trail conducted in the UK. The program will feature additional experts in the fields of surgery, radiation, chemotherapy, and pulmonary medicine. The seminar was designed primarily for physicians needing continuing medical education (CME) credit, but mesothelioma victims, their families, students, physicians in training and other interested parties may attend for a low fee.
Certain progestogens linked to higher brain tumor risk in women, study suggests